Search the Newsreel

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis Pharma A/S announced it will report its second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before U.S. financial markets open. The company will also host a conference call and live webcast on the same day at …

TerrAscend Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Why TerrAscend Corp. stock is skyrocketing today

Banca Monte Dei Paschi Siena Aktie: 30,6-Milliarden-Angebot von Intesa

ERAS INVESTOR ALERT: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

Hagens Berman is investigating potential securities law violations by Erasca, Inc. (NASDAQ: ERAS) following allegations that the company misled investors about its lead oncology candidate, ERAS-0015. The lawsuit claims Erasca provided a false narrative concerning the drug's competitive advantage, safety, and intellectual property, leading …

LeMaitre Vascular To Go Ex-Dividend On August 20th, 2026 With 0.25 USD Dividend Per Share

LeMaitre Vascular is scheduled to go ex-dividend on August 20th, 2026. The company will be distributing a dividend of $0.25 per share to its shareholders. Investors wishing to receive this dividend should ensure they own shares before the ex-dividend date.

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

LeMaitre Vascular, Inc. announced its participation in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, where management will hold investor meetings. The company, a provider of devices for peripheral vascular disease, aims to connect with investors regarding its …

Ascentage Pharma Group International - ADR (AAPG) News, Articles, Events & Latest Updates

This article compiles recent news and updates concerning Ascentage Pharma Group International - Unsponsored ADR (AAPG). Several reports from Zacks and MarketBeat highlight Wall Street analysts' predictions of significant upside potential for AAPG, ranging from 152.23% to 160.09%. Other news items cover fluctuations in …

Ascendis Pharma (ASND) reports new TransCon CNP achondroplasia trial data

Ascendis Pharma (ASND) has reported positive new data from its Phase 2 COACH trial for achondroplasia, demonstrating durable growth in children treated with a combination of TransCon CNP and TransCon hGH. The combination therapy achieved annualized growth velocity at or above the 97th percentile, …

Cascades Reports Results for the Second Quarter of 2026

Erasca, Inc. Deadline: ERAS Investors with Losses in Excess of $100K Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

Rosen Law Firm is reminding investors of Erasca, Inc. (NASDAQ: ERAS) who purchased common stock between January 14, 2025, and April 26, 2026, about the August 10, 2026 deadline to serve as lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Erasca …

CapitaLand Ascendas REIT (SGX:A17U) Stock Gains Lean On One Off Profit

LeMaitre Vascular (LMAT) Hit by Profit Taking

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

Ascendis Announces COACH Week 78 Results and Provides

Ascendis Pharma announced positive 78-week results from its COACH trial for achondroplasia, showing durable, proportional growth with combination therapy (TransCon CNP + TransCon hGH). The company also provided an update on YUVIWEL (TransCon CNP) uptake in the U.S. and highlighted durable benefits from TransCon …

Earnings Flash (CAS.TO) Cascades Inc. Reports Q2 Revenue C$1.22B, vs. FactSet Est of C$1.2B

LeMaitre Vascular (LMAT) Stock Price Hit By Revenue Guidance Cut

Segall Bryant & Hamill LLC Purchases New Shares in Ardmore Shipping Corporation $ASC

Segall Bryant & Hamill LLC has acquired a new position of 67,765 shares in Ardmore Shipping Corporation (NYSE:ASC) worth approximately $1.03 million during the first quarter. This purchase contributes to institutional investors collectively owning 62.22% of the company. Ardmore Shipping has also reported strong …

CapitaLand Ascott Trust to acquire Coliwoo Midtown in Singapore for S$134 million

Stocks to watch: DBS, Keppel, CapitaLand Ascendas Reit, CapitaLand Ascott Trust, CAReit, CSE Global, Coliwoo

Cascades Inc. 2026 Q2 - Results - Earnings Call Presentation (TSX:CAS:CA) 2026-08-06

TerrAscend (OTC: TSNDF) posts Q2 2026 loss, adds debt and exits Michigan

CapitaLand Ascott Trust to acquire Coliwoo Midtown for S$134 million

Should CapitaLand Ascendas REIT’s New US and Spanish Logistics Buys Require Action From (SGX:A17U) Investors?

LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year Low on Analyst Downgrade

LeMaitre Vascular (NASDAQ:LMAT) shares hit a new 52-week low after Wells Fargo downgraded its price target and maintained an equal-weight rating, amidst a broader shift in analyst sentiment to "Hold." The company's Q2 revenue and EPS, despite year-over-year growth, missed analyst expectations, leading to …

LeMaitre Vascular, Inc. Stock 12‑Month Price Target Cut to $116.25, Implies 10% Upside

LeMaitre Vascular, Inc.'s average 12-month price target has been lowered from $118.75 to $116.25 by 8 analysts, suggesting a 10% upside from its Aug. 4 closing price. The consensus rating remains a "Buy" from 9 analysts, with 5 recommending Buy and 4 recommending Hold.

Boise Cascade Company 2026 Q2 - Results - Earnings Call Presentation (NYSE:BCC) 2026-08-05

Boise Cascade Company (BCC) released its Q2 2026 earnings call presentation, reporting an EPS of $1.63, which beat estimates by $0.42. The company also announced revenue of $1.83 billion, surpassing expectations by $59.45 million and showing a 5.24% year-over-year increase. This presentation was published …

ASND Price Today: Ascendis Pharma A/S Stock Price, Quote & Chart | MEXC

This article provides current stock information for Ascendis Pharma A/S (ASND) on MEXC, detailing its live price, key market data like market cap and trading volume, and recent price performance. It also includes an FAQ section addressing common investor questions about the company's stock, …

LeMaitre Vascular stock hits 52-week low at 79.38 USD

LeMaitre Vascular (LMAT) stock recently hit a 52-week low at $79.38, despite having a strong 1-year return of nearly 25% and being up over 31% year-to-date. The medical device maker is trading below its Fair Value estimate, with analysts setting price targets between $100 …

LeMaitre Vascular Down Over 22%, On Track for Largest Percent Decrease Since October 2008 -- Data Talk

LeMaitre Vascular Inc. (LMAT) experienced a significant drop of over 22%, trading at $82.06, which would mark its lowest close since January 2026. This decline puts the company on track for its largest percentage decrease since October 2008. The stock is down 30.1% from …

Erasca earnings on deck: Can pipeline progress offset losses?

Erasca Inc. is set to report second-quarter results, with investor focus primarily on updates regarding its pan-RAS cancer drug, ERAS-0015, rather than expected financial losses. Despite being pre-revenue, analysts have a "Buy" rating on the stock with a significant price target, driven by promising …

LeMaitre Vascular (NASDAQ:LMAT) Price Target Cut to $94.00 by Analysts at Wells Fargo & Company

Wells Fargo & Company analysts have cut their price target for LeMaitre Vascular (NASDAQ:LMAT) to $94.00 from $104.00, maintaining an "equal weight" rating. This adjustment follows the company's recent earnings report where Q2 EPS of $0.74 missed the consensus estimate of $0.81, and revenue …

Ascentage Pharma (AAPG) sets August 19 board meeting on results

Ascentage Pharma Group International (AAPG) has announced a board meeting scheduled for August 19, 2026. The main purpose of this meeting is to review and approve the company's unaudited interim results for the six months ending June 30, 2026, and to authorize their publication. …

CORRECTION: Ascentage Pharma to Report 2026 Six Month

Ascentage Pharma Group International has issued a correction regarding the timing of its 2026 Six Month Interim Results announcement and corporate update. The event will now take place at 7:00 am Eastern Daylight Time (EDT) on August 19, 2026, with an English language webcast …

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces $0.25 Quarterly Dividend

LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend of $0.25 per share, payable on September 3rd to shareholders of record on August 20th. This announcement comes despite the company missing analyst expectations for both Q2 revenue and EPS, and subsequently lowering its full-year 2026 …

Boise Cascade (NYSE: BCC) director sells 1,930 shares at $84.58

Boise Cascade Co director Kristopher J. Matula sold 1,930 shares of common stock at $84.58 per share on August 5, 2026, in an open market or private transaction. Following this sale, Matula directly holds 13,982 shares of Boise Cascade common stock. The transaction was …

LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by Barrington Research